Department of Cell & Molecular Biology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
Compr Physiol. 2019 Mar 14;9(2):665-714. doi: 10.1002/cphy.c180022.
Genome engineering using programmable nucleases is a rapidly evolving technique that enables precise genetic manipulations within complex genomes. Although this technology first surfaced with the creation of meganucleases, zinc finger nucleases, and transcription activator-like effector nucleases, CRISPR-Cas9 has been the most widely adopted platform because of its ease of use. This comprehensive review presents a basic overview of genome engineering and discusses the major technological advances in the field. In addition to nucleases, we discuss CRISPR-derived base editors and epigenetic modifiers. We also delve into practical applications of these tools, including creating custom-edited cell and animal models as well as performing genetic screens. Finally, we discuss the potential for therapeutic applications and ethical considerations related to employing this technology in humans. © 2019 American Physiological Society. Compr Physiol 9:665-714, 2019.
利用可编程核酸酶进行基因组工程是一种快速发展的技术,可实现复杂基因组内的精确基因操作。尽管这项技术最初是随着 Meganucleases、锌指核酸酶和转录激活因子样效应核酸酶的出现而出现的,但由于其易于使用,CRISPR-Cas9 已成为使用最广泛的平台。这篇全面的综述介绍了基因组工程的基本知识,并讨论了该领域的主要技术进展。除了核酸酶,我们还讨论了 CRISPR 衍生的碱基编辑器和表观遗传修饰剂。我们还深入探讨了这些工具的实际应用,包括创建定制编辑的细胞和动物模型以及进行遗传筛选。最后,我们讨论了将该技术应用于人类的治疗应用的潜力和相关的伦理考虑。